Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-12-001053
Filing Date
2012-05-15
Accepted
2012-05-15 07:01:25
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 biostarpharma10q033112.htm 10-Q 1012440
2 ex31-1.htm EX-31.1 17333
3 ex31-2.htm EX-31.2 17799
4 ex32-1.htm EX-32.1 6404
5 ex32-2.htm EX-32.2 6274
  Complete submission text file 0001185185-12-001053.txt   3224377

Data Files

Seq Description Document Type Size
6 bspm-20120331.xml EX-101.INS 456978
7 bspm-20120331.xsd EX-101.SCH 17629
8 bspm-20120331_cal.xml EX-101.CAL 27244
9 bspm-20120331_def.xml EX-101.DEF 86307
10 bspm-20120331_lab.xml EX-101.LAB 104445
11 bspm-20120331_pre.xml EX-101.PRE 87455
Mailing Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046
Business Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046 011-86-29-33686638
Biostar Pharmaceuticals, Inc. (Filer) CIK: 0001418133 (see all company filings)

EIN.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34708 | Film No.: 12840986
SIC: 2834 Pharmaceutical Preparations